drugset / Trial / NCT01154634

Study to Investigate the Pharmacodynamic Effect of a Single Dose of AZD2516 in Healthy Male Subjects

NCT01154634 ↗

Phase 2 Completed 20 enrolled AstraZeneca
RandomizedCrossoverTriple-blindBasic science

Summary

The purpose of this study is to investigate the pharmacodynamic effect of AZD2516 in healthy male subjects.

Timeline

Start
2010-05
Primary completion
2010-09
Completion
2010-09

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD2516 Unknown 5 mg Oral
Subject AZD2516 Unknown 16 mg Oral
Subject AZD2516 Unknown 40 mg Oral